Open research questions in Pancreatitis Pathology and Treatment
437 gap statements mined from Pancreatitis Pathology and Treatment papers in our 7.9M-paper local library, which holds 2,247 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Pancreatitis Pathology and Treatment? See the ranked Medicine journals.
What the literature leaves open
The gap is the need for a biomarker that reliably rules out post-ERCP pancreatitis within the first hour post-procedure. Available biomarkers have limitations in terms of kinetic profiles, clinical accessibility, and cost.
Urinary Trypsinogen-2 for Early Prediction of Post-ERCP Pancreatitis: Faster Answers, Familiar Trade-offs · 2026 · DOIThe paper highlights the need to address these challenges through assay harmonization and integration into multi-marker diagnostic models.
Reappraising Urinary Amylase in Acute Pancreatitis: Methodological and Biological Heterogeneity Underlying Diagnostic Controversy · 2026 · DOIWhile direct pancreatic trauma is associated with high rates of infection, organ failure, and mortality, little is known about the pancreas as a potential secondary target and remote trauma organ and thereby as a booster of systemic injury.
How non-obstructing stones such as microlithiasis or sludge cause pancreatitis has not been studied.
NLRP3 Inflammasome Activation‐Induced Acute Papillitis as a Trigger of Acute Pancreatitis ‐ A Novel Mechanism of Microlithiasis‐Induced Acute Pancreatitis · 2026 · DOIWhile current guidelines advocate conservative management for asymptomatic WOPN, the natural history of these collections remains unclear.
Asymptomatic Walled‐Off Pancreatic Necrosis: A Prospective Study of Natural Course and Risk Factors for Intervention · 2026 · DOIIn summary, this well-designed translational study represents an important and ambitious attempt to clarify the mechanism behind microlithiasis-induced acute pancreatitis, a clinical entity that remains poorly understood.
Microlithiasis‐Induced Acute Papillitis Triggers Acute Pancreatitis: Where Do We Go From Here? · 2026 · DOIWhile its immediate clinical impact is well established, the long-term multisystem comorbidities of AP remain underexplored.
Long‐Term Multisystem Comorbidity Patterns in Acute Pancreatitis: Insights From Observational and Genetic Analysis · 2026 · DOISome patients with chronic pancreatitis (CP) experience nociplastic pain due to central nervous system dysregulation, yet its recognition is limited by the lack of bedside tools.
A Self-Reported Electronic Body Map Identifies Distinct Clinical Pain Phenotypes in Chronic Pancreatitis · 2026 · DOIReliable biomarkers for the diagnosis of chronic pancreatitis (CP) and pancreatic fibrosis severity are lacking, hindering effective treatment and management.
Urine Proteomics Identifies Biomarkers for Diagnosis and Fibrosis Severity in Pediatric Chronic Pancreatitis · 2026 · DOIFat accumulation within the pancreas is increasingly detected during abdominal imaging, but whether an imaging phenotype constitutes a clinically actionable disease remains uncertain.
Fatty Pancreas Disease: An Updated Review of Risk Factors, Diagnosis, Clinical Associations and Management · 2026 · DOIHowever, whether biological age acceleration is associated with pancreatic diseases remains unclear.
Biological aging, circulating lipid biomarkers and pancreatic diseases: a prospective cohort study based on the UK Biobank · 2026 · DOIAcute pancreatitis frequently progresses to systemic inflammation and acute lung injury, but the circulating mediators that couple pancreatic inflammation to remote organ damage remain poorly characterized.
Kupffer Cell–Derived Exosomal S100A8/A9 Promotes Inflammasome–Dependent Pyroptotic Lung Injury in Acute Pancreatitis · 2026 · DOIDysregulation of the von Willebrand factor and its protease, a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13, has been implicated in the pathogenesis of pancreatic necrosis during acute pancreatitis, but the underlying mechanisms remain incompletely understood.
Inhibition of a Disintegrin and Metalloproteinase With Thrombospondin Type 1 Motif, Member 13 Activity by Peptidylarginine Deiminase IV Exacerbates Pancreatic Necrosis in Acute Pancreatitis · 2026 · DOIAlthough sirtuin 2 is linked to inflammation, its precise role in acute pancreatitis remains poorly understood.
Sirtuin 2 Contributes to Pancreatic Injury and Inflammation by Modulating Immediate Early Response 3–Mediated Ferroptosis in Acute Pancreatitis · 2026 · DOIAlthough lipid apheresis (LA) reduces triglyceride (TG) levels, its clinical utility and patient selection criteria remain unclear.
Clinical outcomes of lipid apheresis in hypertriglyceridemia-induced acute pancreatitis: A 10-year triglyceride-stratified retrospective study · 2026 · DOIAzathioprine (AZA), a widely used immunosuppressant, can induce acute pancreatitis (AP), yet the underlying molecular mechanisms remain unclear.
Unraveling the Link Between Azathioprine and Acute Pancreatitis: Integrating Network Toxicology, Machine Learning, and Mendelian Randomization · 2026 · DOIDespite these efforts, early-phase medical interventions to mitigate disease progression are still lacking and acute pancreatitis remains a heterogeneous disease.
Acute Pancreatitis: An Update of Evidence‐Based Management and Recent Trends in Treatment Strategies · 2025 · DOIHowever, the extent to which this association is influenced by the development of chronic pancreatitis or comorbid conditions, such as malignant disease, remains unclear.
Despite these concerns, comprehensive population-based studies on this issue are lacking.
While percutaneous drainage may be required when internal drainage is not feasible, reliable guidelines for managing percutaneous drains are lacking.
Common Practice of Percutaneous Drainage in Necrotising Pancreatitis—A Multicentre Retrospective Study (DRACULA) · 2025 · DOIExocrine pancreatic insufficiency (EPI) is suspected but remains understudied in immunosuppressed conditions such as post-hematopoietic stem cell transplantation (HSCT).
High Incidence and Impact of Suspected Exocrine Pancreatic Insufficiency in Patients Post‐Hematopoietic Stem Cell Transplantation: A Single‐Center Prospective Observational Study · 2025 · DOIFalse-positive lipase elevation is a diagnostic challenge in acute pancreatitis (AP) but has not been systematically studied.
Discordance Between Radiological and Clinical Findings Among Patients Presenting With Elevated Lipase and Abdominal Pain · 2025 · DOIGalectin-9 (Gal-9) modulates macrophage polarization, but its specific effect on PMOs in SAP remains unclear.
Hyaluronic Acid‐Chitosan Nanoparticles Encapsulating Gal‐9 Alleviate Severe Acute Pancreatitis by Promoting M2 Macrophage Polarization · 2025 · DOIFurther trials using quantitative assays with PEP-specific cut-off values are now warranted - Evaluate whether this management strategy improves patient outcomes at an acceptable…
Urinary Trypsinogen-2 for Early Prediction of Post-ERCP Pancreatitis: Faster Answers, Familiar Trade-offs · 2026 · DOIPrioritize assay harmonization, - Prospective evaluation of common versus subgroup-specific diagnostic thresholds, - Integration into multi-marker diagnostic…
Reappraising Urinary Amylase in Acute Pancreatitis: Methodological and Biological Heterogeneity Underlying Diagnostic Controversy · 2026 · DOI
Most-cited papers in Pancreatitis Pathology and Treatment
- Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial · The Lancet · 2008 · 1,153 citations
- Acute Pancreatitis: Diagnosis and Treatment · Drugs · 2022 · 487 citations
- The syndrome of pancreatic insufficiency and bone marrow dysfunction · The Journal of Pediatrics · 1964 · 465 citations
- Alcohol Consumption, Cigarette Smoking, and the Risk of Recurrent Acute and Chronic Pancreatitis · Archives of Internal Medicine · 2009 · 404 citations
- ACG Clinical Guideline: Chronic Pancreatitis · The American Journal of Gastroenterology · 2020 · 359 citations
- Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis · New England Journal of Medicine · 2021 · 261 citations
- Diagnosis and Management of Acute Pancreatitis · Gastroenterology · 2024 · 217 citations
- Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury · Cell Death and Disease · 2021 · 207 citations
- Pediatric Chronic Pancreatitis Is Associated with Genetic Risk Factors and Substantial Disease Burden · The Journal of Pediatrics · 2014 · 191 citations
- Postpancreatectomy Acute Pancreatitis (PPAP) · Annals of Surgery · 2021 · 179 citations
Most recent work
- International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG · United European Gastroenterology Journal · 2026
- Acute pancreatitis: mechanisms and therapeutic approaches · Signal Transduction and Targeted Therapy · 2026
- Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum · JAMA · 2026
- Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial · EClinicalMedicine · 2026
- GLP-1 drugs: New warning after rise in reported deaths from pancreatitis · BMJ · 2026
- Hypertriglyceridaemia-Associated Acute Pancreatitis: Risk Stratification, Drivers, and Prevention of Recurrence · Diseases · 2026
- Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial) · Gut · 2026
- Targeting Thioredoxin Reductase 1 Alleviates Severe Acute Pancreatitis by Modulating Oxidative Stress and Ferroptosis-Related Pathways · Inflammation · 2026
- Naldemedine for the Prevention of Recurrent Acute Pancreatitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial · United European Gastroenterology Journal · 2026
- Immediate or On-Demand Endoscopic Necrosectomy for Necrotizing Pancreatitis: A Randomized Controlled Trial (WONDER-01) · Gastroenterology · 2026
Find a gap in your own Pancreatitis Pathology and Treatment sub-topic
This page shows what the Pancreatitis Pathology and Treatment literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →